Gong, Xueqian
Eli Lilly (United States)
2 papers on CoChatORCID 0009-0005-5647-4090
Most cited papers
- Verified
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade
Schaer, D. A., Beckmann, R. P., Dempsey, J. A., Huber, L., Forest, A., Amaladas, N., Li, Y., Wang, Y. C., Rasmussen, E. R., Chin, D., et al. (2018) · Cell Reports
Cancer Immunotherapy and BiomarkersAdvanced Breast Cancer Therapies
Cited by 469
- Verified
Abstract 3868: Aurora kinase A inhibition overcome adaptive resistance to KRAS G12C inhibitor by G1-checkpoint induced apoptosis in KRAS non-small cell lung cancer
Li, C., Chang, J., Syed, M. U., Nimbalkar, A., Shen, Y., Altschuler, S., Wu, L., Gong, X., & Hata, A. (2023) · Cancer Research
Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free